Boston Megan
SEC CIK 1808923 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BNTC | Benitec Biopharma Inc. | Executive Dir, Dir | 25.9K | — | — | 1 | 2023-08-11 | 2023-08-11 |
Most active insiders at BNTC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | Dir, 10% | $20.00M | — |
| 2 | Cowen Aaron | Dir, 10% | $1.90M | — |
| 3 | Averill Madison Master Fund, Ltd. | 10% | $539.0K | — |
| 4 | BUCHI J KEVIN | Dir | — | — |
Boston Megan made no open-market trades at BNTC in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-14 | 2023-08-11 | BNTC | Benitec Biopharma Inc. | Boston Megan | Executive Dir, Dir | P - Purchase | — | +25.9K | 25.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations